Literature DB >> 11955804

Protection mechanism of Tween 80 during freeze-thawing of a model protein, LDH.

Anna Hillgren1, Jan Lindgren, Maggie Aldén.   

Abstract

The purpose of the study was to investigate the protective mechanism of a non-ionic surfactant, Tween 80, at freeze-thawing with controlled temperature history of a model protein, lactate dehydrogenase (LDH). The system was examined by differential scanning calorimetry (DSC) and infrared spectroscopy (IR). LDH activity assays were performed spectrophotometrically. In all samples, independent of temperature history and addition of surfactant, all water was crystallized to polycrystalline ice at temperatures below -20 degrees C. The size and perfection of the ice crystals could be varied by a range of cooling rates giving different degrees of undercooling. At Tween concentrations below the cmc at crystallization, lower concentrations were required at low cooling rates compared to higher cooling rates to protect LDH. Concentrations above cmc of Tween reduced the protection at a cooling rate of 5 degrees C min(-1) and at quenching in N(2)(l). The amount of Tween needed for complete protection correlated to the surface area of the ice crystals at a certain temperature history. Tween 80 protects LDH from denaturation at freeze-thawing by hindering its destructive interaction with the ice crystals. The protective effect might be obtained when Tween molecules compete with the protein for sites on the ice surface. The optimum concentration of Tween needed for complete protection is dependent on the temperature history.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955804     DOI: 10.1016/s0378-5173(02)00021-2

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Insights into protein-polysorbate interactions analysed by means of isothermal titration and differential scanning calorimetry.

Authors:  Claudia Hoffmann; Alfred Blume; Inge Miller; Patrick Garidel
Journal:  Eur Biophys J       Date:  2009-02-03       Impact factor: 1.733

Review 2.  Considerations for the Use of Polysorbates in Biopharmaceuticals.

Authors:  Michael T Jones; Hanns-Christian Mahler; Sandeep Yadav; Dilbir Bindra; Vincent Corvari; R Matthew Fesinmeyer; Kapil Gupta; Alexander M Harmon; Kenneth D Hinds; Atanas Koulov; Wei Liu; Kevin Maloney; John Wang; Ping Y Yeh; Satish K Singh
Journal:  Pharm Res       Date:  2018-05-24       Impact factor: 4.200

3.  Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

Authors:  Srivalli N Telikepalli; Ozan S Kumru; Cavan Kalonia; Reza Esfandiary; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2014-01-22       Impact factor: 3.534

4.  A new approach to explore the impact of freeze-thaw cycling on protein structure: hydrogen/deuterium exchange mass spectrometry (HX-MS).

Authors:  Aming Zhang; Wei Qi; Satish K Singh; Erik J Fernandez
Journal:  Pharm Res       Date:  2011-02-08       Impact factor: 4.200

Review 5.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

6.  Holographic Characterization of Protein Aggregates in the Presence of Silicone Oil and Surfactants.

Authors:  Priya N O Kasimbeg; Fook Chiong Cheong; David B Ruffner; Jaroslaw M Blusewicz; Laura A Philips
Journal:  J Pharm Sci       Date:  2018-10-10       Impact factor: 3.534

7.  The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics.

Authors:  Ravuri S K Kishore; Sylvia Kiese; Stefan Fischer; Astrid Pappenberger; Ulla Grauschopf; Hanns-Christian Mahler
Journal:  Pharm Res       Date:  2011-03-03       Impact factor: 4.200

Review 8.  Protecting Enzymes from Stress-Induced Inactivation.

Authors:  Samantha Piszkiewicz; Gary J Pielak
Journal:  Biochemistry       Date:  2019-09-05       Impact factor: 3.162

9.  Design and Evaluation of the Highly Concentrated Human IgG Formulation Using Cyclodextrin Polypseudorotaxane Hydrogels.

Authors:  Taishi Higashi; Anna Tajima; Naoko Ohshita; Tatsunori Hirotsu; Irhan Ibrahim Abu Hashim; Keiichi Motoyama; Sawako Koyama; Ruriko Iibuchi; Shiuhei Mieda; Kenji Handa; Tomoaki Kimoto; Hidetoshi Arima
Journal:  AAPS PharmSciTech       Date:  2015-03-17       Impact factor: 3.246

10.  Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.

Authors:  Astrid Hauptmann; Katja Podgoršek; Drago Kuzman; Stanko Srčič; Georg Hoelzl; Thomas Loerting
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.